Quince Therapeutics, Inc. (QNCX): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0001104659-26-097291

Filer

Quince Therapeutics, Inc. (CIK 1662774)